Akari Therapeutics, Plc (AKTX) Ownership

NASDAQ Currency in USD Disclaimer

$0.98

north_east $0.03 (2.93%)
Day's range
$0.98
Day's range
$1.12

Akari Therapeutics, Plc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
SABBY MANAGEMENT, LLC 02/14/2024 164,026 $511,761   -7.90% 0.26%
CORNERSTONE PLANNING GROUP LLC 02/12/2024 5 $16   100.00% 0.00%

Akari Therapeutics, Plcinstitutional Ownership - FAQ's

Who are the largest shareholders of AKTX shares?

During the previous two years, 3 institutional investors and hedge funds held shares of Akari Therapeutics, Plc. The most heavily invested institutionals were:

Advisor Group, Inc.: 1,029

Virtu KCG Holdings LLC: 12,472

VHCP Management, LLC: 158,352

What percentage of Akari Therapeutics, Plc stock is owned by institutional investors?

0.26% of Akari Therapeutics, Plc stock is owned by institutional investors.

How much institutional buying is happening at AKTX ?

Institutional investors have bought a total of 171,853 shares in the last 24 months. This purchase volume represents approximately $168,416 in transactions.